JIMYEONG SON: Open Payments
NPI 1548915622 · MANHASSET, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,957 in 14 payments from 1 company in 2025. Trend: 2023 $125 · 2024 $0 · 2025 $1,957
Consulting: $1,080Food & beverage: $877
| Company | Payments | Amount |
|---|---|---|
| Madrigal Pharmaceuticals | 14 | $1,957 |
Products named: REZDIFFRA.
Industry payments across NY — which companies pay providers there.
